Patents by Inventor Kenya JOHNSON

Kenya JOHNSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine compositions and methods of use
    Patent number: 11911465
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: February 27, 2024
    Assignee: PDS Biotechnology Corporation
    Inventors: Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
  • Stimulation of an immune response by cationic lipids
    Patent number: 11911359
    Abstract: The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antigens.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: February 27, 2024
    Assignee: PDS Biotechnology Corporation
    Inventors: Weihsu Chen, Weili Yan, Kenya Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
  • Vaccine compositions and methods of use
    Patent number: 11904015
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: February 20, 2024
    Assignee: PDS BIOTECHNOLOGY CORPORATION
    Inventors: Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
  • STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS
    Publication number: 20220031650
    Abstract: The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antigens.
    Type: Application
    Filed: July 22, 2021
    Publication date: February 3, 2022
    Inventors: Weihsu Chen, Weili Yan, Kenya Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
  • VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20210361766
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 25, 2021
    Inventors: Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
  • CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20210346496
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of augmenting an immune response in a mammal, and methods of treating diseases in a mammal utilizing the vaccine compositions.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 11, 2021
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS
    Publication number: 20210346333
    Abstract: The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antiigens.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 11, 2021
    Inventors: Weihsu Chen, Weili Yan, Kenya Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
  • CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20210100898
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of argumenting an immune response in a mammal, and methods of treating a diseases in a mammal utilizing the vaccine compositions.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 8, 2021
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions
    Patent number: 10828364
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of argumenting an immune response in a mammal, and methods of treating a diseases in a mammal utilizing the vaccine compositions.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: November 10, 2020
    Assignees: PDS Biotechnology Corporation, THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20190374635
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of argumenting an immune response in a mammal, and methods of treating a diseases in a mammal utilizing the vaccine compositions.
    Type: Application
    Filed: March 28, 2019
    Publication date: December 12, 2019
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • IMPROVED VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20190358318
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
    Type: Application
    Filed: April 18, 2019
    Publication date: November 28, 2019
    Inventors: Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
  • PARTICULATE VACCINE FORMULATIONS
    Publication number: 20190275145
    Abstract: The present disclosure provides vaccine formulations comprising at least one peptide antigen assembly and at least one adjuvant. The disclosure also provides methods of inducing an immune response in a mammal and methods of treating a disease in a mammal utilizing the vaccine formulations.
    Type: Application
    Filed: March 21, 2019
    Publication date: September 12, 2019
    Inventors: Frank Bedu-Addo, Gregory Conn, Eric Jacobson, Carol Mercer, Kenya Johnson
  • Cationic lipid vaccine compositions and methods of use
    Patent number: 10286064
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of augmenting an immune response in a mammal, and methods of treating a disease in a mammal utilizing the vaccine compositions.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 14, 2019
    Assignees: PDS Biotechnology Corporation, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150250872
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid. The disclosure also provides methods of treating a disease in a mammal, methods of preventing a disease in a mammal, and methods of effecting antigen cross presentation to induce a humoral immune response and a cellular immune response in a mammal utilizing the vaccine compositions. Cross presentation of various antigens can be achieved by formulating the specific antigens with cationic lipids possessing adjuvant properties.
    Type: Application
    Filed: September 23, 2013
    Publication date: September 10, 2015
    Inventors: Frank BEDU-ADDO, Eric JACOBSON, Kenya JOHNSON
  • CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20150132340
    Abstract: The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of augmenting an immune response in a mammal, and methods of treating a disease in a mammal utilizing the vaccine compositions.
    Type: Application
    Filed: June 13, 2013
    Publication date: May 14, 2015
    Inventors: Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
  • PARTICULATE VACCINE FORMULATIONS
    Publication number: 20150110823
    Abstract: The present disclosure provides vaccine formulations comprising at least one peptide antigen assembly and at least one adjuvant. The disclosure also provides methods of inducing an immune response in a mammal and methods of treating a disease in a mammal utilizing the vaccine formulations.
    Type: Application
    Filed: September 12, 2012
    Publication date: April 23, 2015
    Applicant: PDS BIOTECHNOLOGY CORPORATION
    Inventors: Frank Bedu-Addo, Gregory Conn, Eric Jacobson, Carol Mercer, Kenya Johnson
  • Stimulation of An Immune Response By Cationic Lipids
    Publication number: 20150093410
    Abstract: The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antigens.
    Type: Application
    Filed: November 3, 2014
    Publication date: April 2, 2015
    Inventors: Weihsu CHEN, Weili YAN, Kenya JOHNSON, Gregory CONN, Frank BEDU-ADDO, Leaf HUANG